(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.87% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.34%.
Qiagen Nv's revenue in 2025 is $2,070,781,000.On average, 23 Wall Street analysts forecast QGEN's revenue for 2025 to be $462,362,940,000, with the lowest QGEN revenue forecast at $434,281,575,000, and the highest QGEN revenue forecast at $479,995,425,000. On average, 24 Wall Street analysts forecast QGEN's revenue for 2026 to be $488,485,140,000, with the lowest QGEN revenue forecast at $461,709,885,000, and the highest QGEN revenue forecast at $514,607,340,000.
In 2027, QGEN is forecast to generate $521,137,890,000 in revenue, with the lowest revenue forecast at $489,355,880,000 and the highest revenue forecast at $551,396,105,000.